192 related articles for article (PubMed ID: 1316464)
21. Interferon regulatory factor 5.2 acts as a transcription repressor of Epidermodysplasia verruciformis-associated human papillomaviruses.
Akgül B; Cürten M; Haigis H; Rogosz I; Pfister H
Arch Virol; 2006 Dec; 151(12):2461-73. PubMed ID: 16773233
[TBL] [Abstract][Full Text] [Related]
22. Splice sites of human papillomavirus type 16 E6 gene or heterologous gene required for transformation by E7 and accumulation of E7 RNA.
Belaguli NS; Pater MM; Pater A
J Med Virol; 1995 Dec; 47(4):445-53. PubMed ID: 8636718
[TBL] [Abstract][Full Text] [Related]
23. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.
Zhao X; Rush M; Schwartz S
J Virol; 2004 Oct; 78(20):10888-905. PubMed ID: 15452209
[TBL] [Abstract][Full Text] [Related]
24. Activity of human papillomavirus type 16 P97 promoter in immortal and tumorigenic human oral keratinocytes.
Kook JK; Kim JH; Min BM
Int J Oncol; 1998 Oct; 13(4):765-71. PubMed ID: 9735407
[TBL] [Abstract][Full Text] [Related]
25. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.
Tan SH; Leong LE; Walker PA; Bernard HU
J Virol; 1994 Oct; 68(10):6411-20. PubMed ID: 8083979
[TBL] [Abstract][Full Text] [Related]
26. Transcription from varicella-zoster virus gene 67 (glycoprotein IV).
Ling P; Kinchington PR; Sadeghi-Zadeh M; Ruyechan WT; Hay J
J Virol; 1992 Jun; 66(6):3690-8. PubMed ID: 1316476
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.
Kyo S; Tam A; Laimins LA
Virology; 1995 Aug; 211(1):184-97. PubMed ID: 7645210
[TBL] [Abstract][Full Text] [Related]
28. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
[TBL] [Abstract][Full Text] [Related]
29. A transcriptional initiator overlaps with a conserved YY1 binding site in the long control region of human papillomavirus type 16.
Tan SH; Baker CC; Stünkel W; Bernard HU
Virology; 2003 Jan; 305(2):486-501. PubMed ID: 12573593
[TBL] [Abstract][Full Text] [Related]
30. Regulatory interactions of transcription factor YY1 with control sequences of the E6 promoter of human papillomavirus type 8.
Pajunk HS; May C; Pfister H; Fuchs PG
J Gen Virol; 1997 Dec; 78 ( Pt 12)():3287-95. PubMed ID: 9400979
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.
Butz K; Hoppe-Seyler F
J Virol; 1993 Nov; 67(11):6476-86. PubMed ID: 8411351
[TBL] [Abstract][Full Text] [Related]
32. Genetic relationship among human papillomaviruses associated with benign and malignant tumours of patients with epidermodysplasia verruciformis.
Krubke J; Kraus J; Delius H; Chow L; Broker T; Iftner T; Pfister H
J Gen Virol; 1987 Dec; 68 ( Pt 12)():3091-103. PubMed ID: 2826651
[TBL] [Abstract][Full Text] [Related]
33. Promoter activity of sequences located upstream of the human papillomavirus types of 16 and 18 late regions.
Geisen C; Kahn T
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2193-200. PubMed ID: 8811019
[TBL] [Abstract][Full Text] [Related]
34. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA.
Weissenborn SJ; Höpfl R; Weber F; Smola H; Pfister HJ; Fuchs PG
J Invest Dermatol; 1999 Jul; 113(1):122-6. PubMed ID: 10417630
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.
Chin MT; Broker TR; Chow LT
J Virol; 1989 Jul; 63(7):2967-76. PubMed ID: 2542607
[TBL] [Abstract][Full Text] [Related]
36. The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element.
Gloss B; Bernard HU
J Virol; 1990 Nov; 64(11):5577-84. PubMed ID: 2170687
[TBL] [Abstract][Full Text] [Related]
37. The cutaneous beta human papillomavirus type 8 E6 protein induces CCL2 through the CEBPα/miR-203/p63 pathway to support an inflammatory microenvironment in epidermodysplasia verruciformis skin lesions.
Vella L; Sternjakob A; Lohse S; Fingerle A; Sperling T; Wickenhauser C; Stöckle M; Vogt T; Roemer K; Ołdak M; Smola S
Front Cell Infect Microbiol; 2024; 14():1336492. PubMed ID: 38510961
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration.
Sperling T; Ołdak M; Walch-Rückheim B; Wickenhauser C; Doorbar J; Pfister H; Malejczyk M; Majewski S; Keates AC; Smola S
PLoS Pathog; 2012; 8(7):e1002833. PubMed ID: 22911498
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16.
Desaintes C; Hallez S; Van Alphen P; Burny A
J Virol; 1992 Jan; 66(1):325-33. PubMed ID: 1309249
[TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region.
Yasumoto S; Taniguchi A; Sohma K
J Virol; 1991 Apr; 65(4):2000-9. PubMed ID: 1848315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
